238 related articles for article (PubMed ID: 24636680)
1. [Treatment of adrenal deficiency: To what issues? By which therapeutic means?].
Reznik Y
Presse Med; 2014 Apr; 43(4 Pt 1):438-43. PubMed ID: 24636680
[TBL] [Abstract][Full Text] [Related]
2. Management of adrenal insufficiency in different clinical settings.
Hahner S; Allolio B
Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
[TBL] [Abstract][Full Text] [Related]
3. Therapies for adrenal insufficiency.
Oki K; Yamane K
Expert Opin Pharmacother; 2007 Jun; 8(9):1283-91. PubMed ID: 17563263
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
5. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey.
Bothou C; Anand G; Li D; Kienitz T; Seejore K; Simeoli C; Ebbehoj A; Ward EG; Paragliola RM; Ferrigno R; Badenhoop K; Bensing S; Oksnes M; Esposito D; Bergthorsdottir R; Drake W; Wahlberg J; Reisch N; Hahner S; Pearce S; Trainer P; Etzrodt-Walter G; Thalmann SP; Sævik ÅB; Husebye E; Isidori AM; Falhammar H; Meyer G; Corsello SM; Pivonello R; Murray R; Bancos I; Quinkler M; Beuschlein F
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2853-63. PubMed ID: 32424397
[TBL] [Abstract][Full Text] [Related]
6. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
[TBL] [Abstract][Full Text] [Related]
7. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
[TBL] [Abstract][Full Text] [Related]
8. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
9. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
10. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
11. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
Flad TM; Conway JD; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1996 Nov; 45(5):529-34. PubMed ID: 8977748
[TBL] [Abstract][Full Text] [Related]
12. Novel strategies for hydrocortisone replacement.
Debono M; Price JN; Ross RJ
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
14. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
15. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
16. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment.
Paragliola RM; Corsello SM
Minerva Endocrinol; 2018 Jun; 43(2):183-197. PubMed ID: 28750490
[TBL] [Abstract][Full Text] [Related]
17. Adrenal insufficiency.
Arlt W
Clin Med (Lond); 2008 Apr; 8(2):211-5. PubMed ID: 18478875
[No Abstract] [Full Text] [Related]
18. Hydrocortisone for adrenal insufficiency.
Elder CJ; Dimitri P
Arch Dis Child Educ Pract Ed; 2015 Oct; 100(5):272-6. PubMed ID: 25561746
[No Abstract] [Full Text] [Related]
19. Adverse effect of phenytoin on mineralocorticoid replacement with fludrocortisone in adrenal insufficiency.
Keilholz U; Guthrie GP
Am J Med Sci; 1986 Apr; 291(4):280-3. PubMed ID: 3706393
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
